Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Avineuro ApS
APS
Bankrupt
CVR 40118144
Ole Maaløes Vej 3
Manufacture of pharmaceutical preparations · NACE 2120
Est. 2018
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2020
DKK 0
EBITDA margin
—
+3% vs 2019
Equity ratio
30.2%
Financial strength
Net profit 2020
DKK -102K
-45% vs 2019
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2019
0M
0%
2020
Key figures
Annual report 2020
Revenue
DKK 0
—
EBITDA
DKK -85K
+3%
Net profit
DKK -102K
-45%
Total assets
DKK 8K
-83%
Equity
DKK 2K
-94%
Employees
—
—
Company information
Legal name
Avineuro ApS
CVR number
40118144
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
20. december 2018
Share capital
DKK 160.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Contact
Address
Ole Maaløes Vej 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of pharmaceutical preparations
Companies in København
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
Income statement
DKK thousands
Item
2019
2020
Revenue
-88
0
Staff expenses
-0
-0
EBITDA
-88
-85
Depreciation & amort.
-0
-0
EBIT
-88
-85
Net financials
0
0
Profit before tax
-88
-85
Tax
-17
17
Net profit
-71
-102
Balance sheet
DKK thousands
Item
2019
2020
Total assets
46
8
Equity
44
2
Long-term debt
0
0
Short-term debt
2
6
Total debt
2
6
Financial ratios
5-year trend
EBITDA margin
-8497000.0%
This company
15.8%
Market median
-53778581% vs market
2019
2020
Equity ratio
30.2%
This company
38.2%
Market median
+21% vs market
2019
2020
Return on equity
-4195.6%
This company
18.4%
Market median
-22902% vs market
2019
2020
Net profit margin
-10203800.0%
This company
8.1%
Market median
-125972940% vs market
2019
2020
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2019
2020
Debt / equity
2.31×
This company
0.62×
Market median
-273% vs market
2019
2020
Annual reports & filings
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via CVR / Virk · Period 2018-12-20 – 2019-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
OI
Olga Ibragimova
Chief Executive Officer
Chief Executive Officer
2020
—
—
LI
Liudmila Iamukova
Chief Executive Officer
Chief Executive Officer
2018
—
—
YB
Yulia Baybikova
Chief Executive Officer
Chief Executive Officer
2021
—
—
CB
Christian Bendik Elmer
Unofficial title
Unofficial title
2022
—
—
UF
Ulrik Fleischer-Michaelsen
Founder
Founder
2018
—
—
NW
Nete Weber
Unofficial title
Unofficial title
2022
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Avineuro Pharmaceuticals, Inc.
Individual
100.0%
100.0%
2018
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Avineuro ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Olga Ibragimova
Chief Executive Officer
0 companies
Liudmila Iamukova
Chief Executive Officer
0 companies
Yulia Baybikova
Chief Executive Officer
0 companies
Christian Bendik Elmer
Unofficial title
0 companies
Ulrik Fleischer-Michaelsen
Founder
0 companies
Nete Weber
Unofficial title
0 companies